Clinical Trials Logo

Avascular Necrosis of Femur Head clinical trials

View clinical trials related to Avascular Necrosis of Femur Head.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01605383 Completed - Clinical trials for Avascular Necrosis of Femur Head

Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head

Start date: May 5, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The present study evaluates the effect of XCEL-MT-OSTEO-ALPHA in osteonecrosis of the femoral head in comparison to the standard treatment of isolated core decompression. XCEL-MT-OSTEO-ALPHA is a tissue engineering product composed by "ex-vivo" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue. The working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration, avoiding the progression to collapse of the femoral head.